Masimo Corp (MASI)
172.96
+3.84
(+2.27%)
USD |
NASDAQ |
Nov 22, 16:00
173.07
+0.11
(+0.06%)
After-Hours: 20:00
Masimo Cash from Financing (Quarterly): -1.60M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -1.60M |
| June 30, 2024 | -91.00M |
| March 31, 2024 | -26.50M |
| December 31, 2023 | -36.30M |
| September 30, 2023 | 19.30M |
| June 30, 2023 | -4.90M |
| March 31, 2023 | -35.20M |
| December 31, 2022 | -4.70M |
| September 30, 2022 | 29.30M |
| June 30, 2022 | 518.00M |
| March 31, 2022 | -22.20M |
| December 31, 2021 | 4.20M |
| September 30, 2021 | 9.90M |
| June 30, 2021 | 3.352M |
| March 31, 2021 | -139.85M |
| December 31, 2020 | -93.25M |
| September 30, 2020 | 6.34M |
| June 30, 2020 | 21.36M |
| March 31, 2020 | 11.25M |
| December 31, 2019 | -3.998M |
| September 30, 2019 | 9.766M |
| June 30, 2019 | -21.27M |
| March 31, 2019 | 6.165M |
| December 31, 2018 | 2.129M |
| September 30, 2018 | 22.52M |
| Date | Value |
|---|---|
| June 30, 2018 | 11.36M |
| March 31, 2018 | -10.23M |
| December 31, 2017 | -17.17M |
| September 30, 2017 | -35.12M |
| June 30, 2017 | 20.93M |
| March 31, 2017 | 27.22M |
| December 31, 2016 | -141.28M |
| September 30, 2016 | -15.44M |
| June 30, 2016 | -54.70M |
| March 31, 2016 | -5.214M |
| December 31, 2015 | -21.31M |
| September 30, 2015 | -26.20M |
| June 30, 2015 | -16.96M |
| March 31, 2015 | 2.392M |
| December 31, 2014 | -2.009M |
| September 30, 2014 | 0.742M |
| June 30, 2014 | 26.08M |
| March 31, 2014 | 1.83M |
| December 31, 2013 | 0.974M |
| September 30, 2013 | 0.578M |
| June 30, 2013 | -7.277M |
| March 31, 2013 | -12.22M |
| December 31, 2012 | -56.59M |
| September 30, 2012 | 0.485M |
| June 30, 2012 | -11.71M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-139.85M
Minimum
Mar 2021
518.00M
Maximum
Jun 2022
8.175M
Average
-2.799M
Median
Cash from Financing (Quarterly) Benchmarks
| Boston Scientific Corp | 7.00M |
| Baxter International Inc | -146.00M |
| Intuitive Surgical Inc | 98.20M |
| Tandem Diabetes Care Inc | -4.519M |
| Glaukos Corp | 9.668M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 25.60M |
| Cash from Investing (Quarterly) | -13.50M |
| Free Cash Flow | 149.60M |
| Free Cash Flow Per Share (Quarterly) | 0.1731 |
| Free Cash Flow to Equity (Quarterly) | 18.40M |
| Free Cash Flow to Firm (Quarterly) | 17.17M |
| Free Cash Flow Yield | 1.59% |